Cognition Therapeutics Inc
CGTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001455365
No open-market purchases or sales by Cognition Therapeutics Inc insiders were filed in the last 90 days; 66 institutions reported holding it in 13F filings for Q2 2026, worth $26.0M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Cognition Therapeutics Inc changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 46 | 2 | 40 | −4 |
| Shares | 5.31M | 171.0K | 4.25M | −885.4K (−17.2%) |
| Value | $8.82M | $283.9K | $1.99M | −$6.54M (−76.7%) |
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (10)
Institutions that held Cognition Therapeutics Inc at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Group AG | 197,859 | $92.8K | 0.00% |
| BlackRock, Inc. | 155,545 | $72.9K | 0.00% |
| Acadian Asset Management LLC | 140,943 | $64.0K | 0.00% |
| Virtu Financial LLC | 57,231 | $27.0K | 0.00% |
| Jane Street Group, LLC | 22,730 | $10.7K | 0.00% |
| Bessemer Group Inc | 13,797 | $6.00K | 0.00% |
| Two Sigma Investments, LP | 11,370 | $5.33K | 0.00% |
| Two Sigma Advisers, LP | 11,000 | $5.16K | 0.00% |
| Advisor Group Holdings, Inc. | 1,800 | $846 | 0.00% |
| JPMorgan Chase & Co | 78 | $37 | 0.00% |
Sold out (14)
Institutions that held Cognition Therapeutics Inc at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| AWM Investment Company, Inc. | 650,000 | $1.08M |
| Timelo Investment Management Inc. | 361,397 | $599.9K |
| AIGH Capital Management LLC | 300,766 | $499.3K |
| Carlson Capital L P | 140,000 | $232.4K |
| Corsair Capital Management, L.P. | 77,433 | $128.5K |
| Envestnet Asset Management Inc | 30,000 | $49.8K |
| Citadel Advisors LLC | 26,950 | $44.7K |
| Baird Financial Group, Inc. | 22,393 | $37.2K |
| Millennium Management LLC | 13,624 | $22.6K |
| Charles Schwab Investment Management Inc | 11,965 | $19.9K |
| Susquehanna International Group, LLP | 10,182 | $16.9K |
| Sandy Spring Bank | 2,000 | $3.32K |
| Royal Bank of Canada | 338 | $1.00K |
| Opal Wealth Advisors, LLC | 500 | $830 |
Not filed for Q3 2024 yet (2)
Institutions that held Cognition Therapeutics Inc at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 152,581 | $253.3K |
| Gratus Capital LLC | 18,424 | $30.6K |